Status:
NOT_YET_RECRUITING
Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Preeclampsia (PE) Risk
Oocyte Donation
Eligibility:
FEMALE
Brief Summary
The IMMUN-OR study aims to study HLA-C/KIR combinations when looking at the risk of development of preeclampsia (PE) in pregnancies after oocyte donation. With the use of oocyte donation currently on ...
Eligibility Criteria
Inclusion
- Every live birth delivery post oocyte donation (mother, child, donor).
Exclusion
- Unknown HLA-C/KIR typing of acceptor, donor or offspring (resumlts of all 3 parties must be present to participate.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2029
Estimated Enrollment :
2325 Patients enrolled
Trial Details
Trial ID
NCT07178652
Start Date
September 1 2025
End Date
August 1 2029
Last Update
September 17 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.